Sold as Presamine, Tofranil, Janimine. Every FDA application for this active ingredient: 3 branded and 37 generic.
As of Nov 15, 2026, FDA lists 40 applications for Imipramine Hydrochloride (sold as Presamine, Tofranil, Janimine), first approved Apr 16, 1959, with 0 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| Imipramine HCl | Part D | $4.7M | +3% | 39,086 |
| Apr 16, 1959 | PresamineNDA 11836 · New molecular entity | Sanofi Aventis US | 22 | Discontinued |
| Oct 2, 1959 | TofranilNDA 11838 · New dosage form | Novartis | 12 | Discontinued |
| Jun 27, 1974 | Imipramine HydrochlorideANDA 83729 | Teva | 38 | Discontinued |
| Nov 15, 1974 | JanimineNDA 17895 · TYPE 6 | Abbott | 8 | Discontinued |
| Apr 20, 1976 | Imipramine HydrochlorideANDA 83745 | Sandoz | 36 | Marketed |
| Apr 20, 1976 | Imipramine HydrochlorideANDA 84937 | Sandoz | 42 | Marketed |
| Apr 20, 1976 | Imipramine HydrochlorideANDA 84936 | Sandoz | 30 | Marketed |
| Aug 5, 1977 | Imipramine HydrochlorideANDA 83799 | Roxane | 3 | Discontinued |
| Jun 19, 1978 | PramineANDA 83827 | Alra | 0 | Discontinued |
| Oct 16, 1978 | Imipramine HydrochlorideANDA 85878 | Watson Labs | 0 | Discontinued |
| Oct 30, 1978 | Imipramine HydrochlorideANDA 85877 | Watson Labs | 0 | Discontinued |
| Feb 4, 1981 | Imipramine HydrochlorideANDA 85875 | Watson Labs | 0 | Discontinued |
| Mar 13, 1981 | Imipramine HydrochlorideANDA 85133 | Sandoz | 4 | Discontinued |
| Mar 13, 1981 | Imipramine HydrochlorideANDA 85200 | Sandoz | 8 | Discontinued |
| Jan 4, 1982 | Imipramine HydrochlorideANDA 87631 | Vangard | 0 | Discontinued |
| Feb 9, 1982 | Imipramine HydrochlorideANDA 87619 | Vangard | 1 | Discontinued |
| Feb 10, 1982 | Imipramine HydrochlorideANDA 87776 | Usl Pharma | 2 | Discontinued |
| Nov 3, 1982 | Imipramine HydrochlorideANDA 88036 | Vangard | 0 | Discontinued |
| Oct 21, 1983 | Imipramine HydrochlorideANDA 88262 | Strides Pharma Intl | 25 | Marketed |
| Oct 21, 1983 | Imipramine HydrochlorideANDA 88276 | Strides Pharma Intl | 26 | Marketed |
| Oct 21, 1983 | Imipramine HydrochlorideANDA 88292 | Strides Pharma Intl | 26 | Marketed |
| May 22, 1984 | Tofranil, Imipramine HydrochlorideANDA 87846 | Specgx LLC | 21 | Discontinued |
| Jul 14, 1987 | Imipramine HydrochlorideANDA 89422 | Par Pharm | 10 | Discontinued |
| Jul 14, 1987 | Imipramine HydrochlorideANDA 89497 | Par Pharm | 10 | Discontinued |
| Jun 5, 1990 | Imipramine HydrochlorideANDA 81048 | Sun Pharm Industries | 20 | Discontinued |
| Jun 5, 1990 | Imipramine HydrochlorideANDA 81049 | Sun Pharm Industries | 22 | Marketed |
| Jun 5, 1990 | Imipramine HydrochlorideANDA 81050 | Sun Pharm Industries | 21 | Marketed |
| Sep 16, 1994 | Imipramine HydrochlorideANDA 84869 | Sandoz | 9 | Discontinued |
| Feb 28, 2008 | Imipramine HydrochlorideANDA 40751 | Oxford Pharms | 3 | Marketed |
| Mar 11, 2010 | Imipramine HydrochlorideANDA 90441 | Chartwell | 3 | Discontinued |
| Oct 24, 2012 | Imipramine HydrochlorideANDA 40903 | Leading | 3 | Marketed |
| — | Imipramine HydrochlorideANDA 85221 | Watson Labs | 0 | Discontinued |
| — | Imipramine HydrochlorideANDA 84252 | Watson Labs | 0 | Discontinued |
| — | Imipramine HydrochlorideANDA 85220 | Watson Labs | 0 | Discontinued |
| — | Imipramine HydrochlorideANDA 86267 | Lederle | 1 | Discontinued |
| — | Imipramine HydrochlorideANDA 86268 | Lederle | 1 | Discontinued |
| — | Imipramine HydrochlorideANDA 86269 | Lederle | 1 | Discontinued |
| — | Imipramine HydrochlorideANDA 86765 | Novartis | 0 | Discontinued |
| — | Imipramine HydrochlorideANDA 88223 | West Ward | 0 | Discontinued |
| — | Imipramine HydrochlorideANDA 88222 | West Ward | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA